NCT03565289 - PRospective Prostate biOmarker Study | Biotech Hunter

Enrollment

455

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

January 31, 2020

Conditions

Indication for Prostate Biopsy Due to Suspected Prostate Cancer

Interventions

DIAGNOSTIC_TEST

Blood sample collection

During a routine blood draw an additional tube of blood will be taken for the study.

Trial Locations (11)

Rigshospitalet, Copenhagen

Ordensklinikum Linz, Linz

Medizinische Universität Innsbruck, Innsbruck

Helios Klinikum Bad Saarow, Bad Saarow

Martini Klinik am UKE GmbH, Hamburg

Städtisches Klinikum Braunschweig gGmbH, Braunschweig

Marien-Hospital Herne, Herne

Universitätsklinikum Münster, Münster

Malteser Krankenhaus Bonn/Rhein-Sieg, Bonn

Universitätsklinikum Frankfurt, Frankfurt

Daikonie Klinikum Stuttgart, Stuttgart

All Listed Sponsors

lead

ProteoMediX AG

INDUSTRY